VTAK (Catheter Precision, Inc.) Stock Analysis - Politician Trades

Catheter Precision, Inc. (VTAK) is a publicly traded Healthcare sector company. As of May 21, 2026, VTAK trades at $0.81 with a market cap of $2.23M and a P/E ratio of -0.05. VTAK moved -3.83% today. Year to date, VTAK is -61.62%; over the trailing twelve months it is -85.28%. Its 52-week range spans $0.75 to $33.06. Rallies surfaces VTAK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded VTAK stock?

Rallies tracks politician and congressional stock disclosures for VTAK, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

VTAK Key Metrics

Key financial metrics for VTAK
MetricValue
Price$0.81
Market Cap$2.23M
P/E Ratio-0.05
EPS$-15.90
Dividend Yield0.00%
52-Week High$33.06
52-Week Low$0.75
Volume792
Avg Volume0
Revenue (TTM)$819.00K
Net Income$-17.70M
Gross Margin92.31%

Latest VTAK News

Recent VTAK Insider Trades

  • COLOMBATTO MARTIN J sold 3 (~$1.201) on Jan 29, 2025.
  • JENKINS DAVID A bought 9.53K (~$5.69K) on Jan 23, 2024.
  • JENKINS DAVID A bought 9.53K (~$4.09K) on Jan 22, 2024.

VTAK Analyst Consensus

VTAK analyst coverage data. Average price target: $0.00.

Common questions about VTAK

Which politicians traded VTAK stock?
Rallies tracks politician and congressional stock disclosures for VTAK, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in VTAK?
Yes. Rallies tracks politician and congressional stock disclosures for VTAK, including reported purchases, sales, dates, owners, and trade amounts when available.
Is VTAK research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VTAK. It does not provide personalized investment advice.
VTAK

VTAK